New funding competitions launched in July 2024 by SBRI Healthcare in England

In July 2024, SBRI (Small Business Research Initiative) Healthcare launched new funding competitions in four priority areas: antimicrobial resistance, women’s health, urgent & emergency care, and stroke. SBRI Healthcare is funded by the NHS Accelerated Access Collaborative and supported by the Health Innovation Network (HIN). 

All types of innovations are eligible, including but not limited to medical devices, in-vitro diagnostics, digital health solutions and AI solutions, behavioral interventions, and service improvements.

Competition 25 for antimicrobial resistance and women’s health invites early-stage innovations. Phase 1 is aimed to show the technical and commercial feasibility of the proposed concept. The development contracts will be for a maximum of 6 months and up to £100,000 (excluding VAT) per project. Only those projects that have successfully completed Phase 1 will be eligible for Phase 2, which is intended to develop and evaluate prototypes or demonstration units over a maximum of 12 months with up to £800,000 (excluding VAT).

Applications for Competition 25 Phase 1 can be submitted from July 17 to August 28, 2024.

Competition 26 Phase 3 for urgent & emergency care and stroke is focused on late-stage innovations with the aim to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators to make purchasing or other recommendations and decisions. This funding competition runs in one phase only and is intended to facilitate the implementation of developed innovations. Contracts will be for a maximum of 12 months and up to £500,000 (excluding VAT) per project.

Applications for Competition 26 Phase 3 can be submitted from July 31 to September 18, 2024.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.